Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 3 , Pages 152-160 , July 2005

Neuraxial infusions

  • Phillip C. Phan, MD
    • ,
  • Madhuri Are, MD
    • ,
  • Allen W. Burton, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Allen W. Burton, MD, Department of Anesthesiology and Pain Medicine, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe-042, Houston TX 77030.

References 

  1. World Health Organization . Cancer Pain Relief and Pallative Care . In: (ed 2). Geneva: World Health Organization; 1996;p. 12–15
  2. Lesage P , Portenoy RK . Trends in cancer pain management . Cancer Control . 1999;6:136–145
  3. Miguel R . Interventional treatment of cancer pain (the fourth step in the WHO analgesic ladder?) . Cancer Control . 2000;7:149–156
  4. Krames E . Interventional pain management (appropriate when less invasive therapies fail to provide adequate analgesia) . Med Clin North Am . 1999;83:787–808
  5. Waldman SD . The role of spinal opioids in management of cancer pain . J Pain Symptom Manage . 1990;5:163
  6. Ventafidda V , Spoldi E , Caraceni A , et al.   Intraspinal morphine for cancer pain . Acta Anaesthesiol Scand Suppl . 1987;85:47–53
  7. Chaney MA . Side effects of intraspinal and epidural opioids . Can J Anaesth . 1995;42:891–903
  8. Saek S , Yaksh T . Suppression of nocieceptive responses by spinal mu agonists (effects of stimulus intensity and agonist efficacy) . Anesth Analg . 1993;77:265
  9. Yaksh TL . Spinal opiates (a review of their effect on spinal function with an emphasis on pain processing) . Acta Anaesthesiol Scand . 1987;31:25
  10. Sanowski M , Yaksh TL . Spinal administration of receptor-selective drugs as analgesics (new horizons) . J Pain Symptom Manage . 1990;5:204
  11. Yaksh TL , Noueihed R . The physiology and pharmacology of spinal opioids . Annu Rev Pharmacol Toxicol . 1985;25:433
  12. Zieglgansberger W . Opiate actions on mammalian spinal neurons . Int Rev Neurobiol . 1984;25:243
  13. Coda BA , Brown MC , Schaffer R , et al.   Pharmacology of epidural fentanyl, alfentanil, and sulfentanil in volunteers . Anesthesiology . 1994;81:1149–1161
  14. Jacobson L , Chabal C , Brody MC , et al.   Intrathecal methadone (a dose-response study and comparison with intrathecal morphine) . Pain . 1990;43:141–148
  15. Hassenbusch SJ , Portenoy RK , Cousins M , et al.   Polyanalgesic Consensus Conference 2003 (an update on the management of pain by intraspinal drug delivery- report of an expert panel) . J Pain Symptom Manage . 2004;27:540–563
  16. Payne R . CSF distribution of opioids in animal and man . Acta Anesthesiol Scand . 1987;31(suppl 85):38
  17. Cousins MJ , Mather LE . Intrathecal and epidural administration of opiates . Anesthesiology . 1984;28:1–38
  18. Max MB , Inturrisi CE , Kaido RF , et al.   Epidural and intrathecal opiates (CSF and plasma profiles in patients with chronic cancer pain) . Clin Pharmacol Ther . 1985;38:631
  19. Gourley RF , Cherry BA , Cousins MJ . Cephalad migration of morphine in CSF following lumbar epidural administration in patients with cancer pain . Pain . 1985;23:317
  20. Miguel R , Barlow I , Morrell M , et al.   A prospective, randomized double-blinded comparison of epidural and intravenous sulfentanil infusions . Anesthesiology . 1994;81:346–352
  21. Sullivan AF , Dashwood MR , Dickenson AN . Alpha-2 adrenoreceptor modulation of nocieceptor in rat spinal cord (location, effects, and interactions with morphine) . Eur J Pharmacol . 1987;138:169–177
  22. Yaksh TL . Pharmacology of spinal adrenergic systems, which modulate spinal nociceptive processing . Pharmacol Biochem Behav . 1985;22:845–858
  23. Ono H , Mishima A , Ono S , et al.   Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists . Neuropharmacology . 1991;30:585–589
  24. Segal IS , Jarvis DI , Duncan SR , et al.   Clinical efficacy of oral-transdermal clonidine combinations during the perioperative period . Anesthesiology . 1991;74:220–225
  25. Surrott B , Conway EL , Macarrone C , et al.   Clonidine (understanding its disposition, sites, and mechanism of action) . Clin Exp Pharmacol Physiol . 1987;14:471–479
  26. Fibs KS , Goudas LC , Palran O , et al.   Hemodynamic and analgesic profile after intrathecal clonidine in humans. A dose-response study . Anesthesiology . 1994;81:591–601
  27. Eisenach SC , DuPen S , Dubois M , et al.   Epidural clonidine analgesia for intractable cancer pain . Pain . 1995;61:391–399
  28. Hassenbusch SJ , Gunes S , Wachsman S , et al.   Intrathecal clonidine in the treatment of intractable pain (a phase I/II study) . Pain Med . 2002;3:8–91
  29. Coombs DW , Saunder RL , Fratkin SD , et al.   Continuous intrathecal hydromorphone and clonidine for intractable cancer pain . J Neurosurg . 1986;64:890–894
  30. Eisenach SC , Tong CY . Site of hemodynamic effects of intrathecal alpha 2-adrenergic agonists . Anesthesiology . 1991;74:766–771
  31. Deer TR , Caraway DL , Kim CK , et al.   Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine . Spine J . 2002;2:274–278
  32. Walker SM , Goudas LC , Cousins MJ , et al.   Combination spinal analgesic chemotherapy (a systematic review) . Anesth Analg . 2002;95:674–715
  33. Buchser E , Durrer A , Chedel D , et al.   Efficacy of intrathecal bupivacaine (how important is flow rate?) . Pain Med . 2004;5:248–252
  34. Staats PS , Yearwood T , Chapapata SG , et al.   Intrathecal ziconotide in treatment of refractory pain in patients with cancer or AIDS (a randomized controlled trial) . J Am Med Assoc . 2004;291:63–70
  35. Almeida RA , Lauretti GR , Mattis AL . Antinociceptive effect of low-dose intrathecal neostigmine combined with intrathecal morphine following gynecologic surgery . Anesthesiology . 2003;98:495–498
  36. Grant GJ , Piskoun B , Bansinath M . Intrathecal administration of liposomal neostigmine prolongs analgesia in mice . Acta Anaesthesiol Scand . 2002;46:90–94
  37. Naguib M , Yaksh TL . Antinocieceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems . Anesthesiology . 1994;80:1338–1348
  38. Hood DD , Eisenach SC , Tuttle R . Phase I safety assessment of intrathecal neostigmine methylsulfate in humans . Anesthesiology . 1995;82:331–345
  39. Bennett G , Burchiel K , Buchser E , et al.   Clinical guidelines for intraspinal infusion (report of an expert panel) . J Pain Symptom Manage . 2000;20:537–543
  40. Smith TJ , Coyne PJ . How to use implantable intrathecal drug delivery systems for refractory chronic pain . J Support Oncol . 2003;1:73–76
  41. Kedlaya D , Reynolds L , Waldman S . Epidural and intrathecal analgesia for cancer pain . Best Pract Res Clin Anaesthesiol . 2002;16:651–655
  42. Krames E . Implantable devices for pain control (spinal cord stimulation and intrathecal therapies) . Best Pract Res Clin Anaesthesiol . 2002;16:619–649
  43. Gallagher RM . Epidural and intrathecal cancer pain management (prescriptive care for quality of life) . Pain Med . 2004;5:235
  44. Lubenow T , Ivankovich A . Intraspinal narcotics for treatment of cancer pain . Semin Surg Oncology . 1990;6:173
  45. Ferrante FM , Bedder M , Caplan KA , et al.   Practice guidelines for cancer pain management . Anesthesiology . 1996;94:1243–1257
  46. Patt RB , Jain S . Therapeutic decision-making for invasive procedures . In:  Patt RB editors. Cancer Pain . Philadelphia, PA: Lippincott; 1993;p. 275–283
  47. Crul BJ , Delhaas EM . Technical complications during long-term subarachnoid or epidural administration administration of morphine in terminally ill cancer patients (a review of 140 cases) . Reg Anesth . 1991;16:209–213
  48. Hans JE , Peters J , Eikermann M . Epidural analgesia at the end of life (facing empirical contraindications) . Anesth Analg . 2003;97:1740–1742
  49. Mercadante S . Epidural treatment in advanced cancer patients . (letter) Anesth Analg . 2004;98:1503
  50. Burton AW , Rajagopal A , Shah HN , et al.   Epidural and intrathecal analgesia is effective in treating refractory cancer pain . Pain Med . 2004;5:238–246
  51. Bedder MD , Burchiel JK , Larson A . Cost analysis of two narcotic delivery systems . J Pain Symptom Manage . 1991;6:397–409
  52. Hassenbusch SJ . Cost modeling for alternative routes of administration of opioids for cancer pain . Oncology . 1999;13:63–67
  53. Burton AW , Hassenbusch SJ . The double catheter technique for intrathecal medication trial (a brief clinical note and report of five cases) . Pain Med . 2001;2:352–354
  54. Krames ES . Intraspinal opioid therapy for chronic nonmalignant pain (current practice and clinical guidelines) . J Pain Symptom Manage . 1996;11:333–352
  55. Smith TJ , Staats P , Deer T , et al.   Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain (impact on pain, drug-related toxicity, and survival) . J Clin Oncol . 2002;20:4040–4049
  56. Rauck RL , Cherry D , Boyer MF , et al.   Long-term intrathecal opioid therapy with a patient-activated implanted delivery system for the treatment of refractory cancer pain . J Pain . 2003;4:441–447
  57. Hassenbusch SJ , Pillay PK , Magdinec M , et al.   Constant infusion of morphine for intractable cancer pain using implanted pump . J Neurosurg . 1990;73:405–409
  58. Krames ES . Continuous infusion of spinally administered narcotics for the relief of pain due to malignant disorders . Cancer . 1985;56:696–702
  59. Gilmer-Hill HS , Boggan JE , Smith KA , et al.   Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain (a review of the literature) . Surg Neurol . 1999;51:12–15
  60. Follett KA . Intrathecal analgesia and catheter-tip inflammatory masses . Anesthesiology . 2003;99:5–6
  61. Burton AW , Conroy B , Garcia E , et al.   Illicit substance abuse via an implanted intrathecal pump . Anesthesiology . 1998;89:1264–1267
  62. Boviatsis EJ , Kouyialis AT , Boutsikakis I , et al.   Infected CNS infusion pumps. Is there a chance for treatment without removal? . Acta Neurochir (Wien) . 2004;146:463–467

PII: S1084-208X(05)00049-2

doi: 10.1053/j.trap.2005.06.008

Techniques in Regional Anesthesia & Pain Management
Volume 9, Issue 3 , Pages 152-160 , July 2005

Article Tools

* Image Usage & Resolution